Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Perturbation of the natural killer cell compartment during primary human immunodeficiency virus 1 infection primarily involving the CD56 bright subset.

Mantegani P, Tambussi G, Galli L, Din CT, Lazzarin A, Fortis C.

Immunology. 2010 Feb;129(2):220-33. doi: 10.1111/j.1365-2567.2009.03171.x. Epub 2009 Aug 4.

2.

HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response.

Ward J, Davis Z, DeHart J, Zimmerman E, Bosque A, Brunetta E, Mavilio D, Planelles V, Barker E.

PLoS Pathog. 2009 Oct;5(10):e1000613. doi: 10.1371/journal.ppat.1000613. Epub 2009 Oct 2.

3.

Inflammatory papillomatous hyperplasia and epidermal necrosis in a transgenic rat for HIV-1.

Cedeno-Laurent F, Bryant J, Fishelevich R, Jones OD, Deng A, Eng ML, Gaspari AA, Trujillo JR.

J Dermatol Sci. 2009 Feb;53(2):112-9. doi: 10.1016/j.jdermsci.2008.08.015. Epub 2008 Nov 11.

4.

Validation of the SCID-hu Thy/Liv mouse model with four classes of licensed antiretrovirals.

Stoddart CA, Bales CA, Bare JC, Chkhenkeli G, Galkina SA, Kinkade AN, Moreno ME, Rivera JM, Ronquillo RE, Sloan B, Black PL.

PLoS One. 2007 Aug 1;2(7):e655.

5.

Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1.

Sun Z, Denton PW, Estes JD, Othieno FA, Wei BL, Wege AK, Melkus MW, Padgett-Thomas A, Zupancic M, Haase AT, Garcia JV.

J Exp Med. 2007 Apr 16;204(4):705-14. Epub 2007 Mar 26.

6.

Adverse cutaneous drug eruptions and HIV: a clinician's global perspective.

Todd G.

Dermatol Clin. 2006 Oct;24(4):459-72, vi. Review.

PMID:
17010776
7.

Immune dysregulation in atopic dermatitis.

Ong PY, Leung DY.

Curr Allergy Asthma Rep. 2006 Sep;6(5):384-9. Review.

PMID:
16899200
8.

Etiopathogenesis of seborrheic dermatitis.

Valia RG.

Indian J Dermatol Venereol Leprol. 2006 Jul-Aug;72(4):253-5. Review. No abstract available.

9.

Acquired immunodeficiency syndrome-related malignancies in the era of highly active antiretroviral therapy.

Bernstein WB, Little RF, Wilson WH, Yarchoan R.

Int J Hematol. 2006 Jul;84(1):3-11. Review.

PMID:
16867895
10.

Immunology of AIDS related to psoriasis.

Duvic M.

J Invest Dermatol. 1990 Nov;95(5 Suppl):38S-40S. Review.

11.

Patterns of skin manifestations and their relationships with CD4 counts among HIV/AIDS patients in Cameroon.

Josephine M, Issac E, George A, Ngole M, Albert SE.

Int J Dermatol. 2006 Mar;45(3):280-4.

PMID:
16533229
12.

Dermatologic manifestations of HIV infection.

Maurer TA.

Top HIV Med. 2005 Dec-2006 Jan;13(5):149-54. Review.

13.

Eosinophilic folliculitis: before and after the introduction of antiretroviral therapy.

Rajendran PM, Dolev JC, Heaphy MR Jr, Maurer T.

Arch Dermatol. 2005 Oct;141(10):1227-31.

PMID:
16230559
14.

The Tetratricopeptide repeat domain 7 gene is mutated in flaky skin mice: a model for psoriasis, autoimmunity, and anemia.

Helms C, Pelsue S, Cao L, Lamb E, Loffredo B, Taillon-Miller P, Herrin B, Burzenski LM, Gott B, Lyons BL, Keppler D, Shultz LD, Bowcock AM.

Exp Biol Med (Maywood). 2005 Oct;230(9):659-67.

PMID:
16179734
15.

A new endogenous retroviral sequence is expressed in skin of patients with psoriasis.

Molès JP, Tesniere A, Guilhou JJ.

Br J Dermatol. 2005 Jul;153(1):83-9.

PMID:
16029331
16.

Psoriasis.

Schön MP, Boehncke WH.

N Engl J Med. 2005 May 5;352(18):1899-912. Review. No abstract available.

17.

Porphyria cutanea tarda in a patient with HIV-infection.

Almehmi A, Deliri H, Szego GG, Teague AC, Pfister AK, Martin SA.

W V Med J. 2005 Jan-Feb;101(1):19-21.

PMID:
15861867
18.

Human endogenous retroviruses and their possible impact on dermatology.

Rebora A.

J Am Acad Dermatol. 2005 May;52(5):E7. Review. No abstract available.

PMID:
15858463
19.

Etiology of pruritic papular eruption with HIV infection in Uganda.

Resneck JS Jr, Van Beek M, Furmanski L, Oyugi J, LeBoit PE, Katabira E, Kambugu F, Maurer T, Berger T, Pletcher MJ, Machtinger EL.

JAMA. 2004 Dec 1;292(21):2614-21.

PMID:
15572719
20.

Immune restoration disease after antiretroviral therapy.

French MA, Price P, Stone SF.

AIDS. 2004 Aug 20;18(12):1615-27. Review.

PMID:
15280772

Supplemental Content

Support Center